Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 10 results

Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors

research Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors

12 citations , December 2022 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

research Cytokine-Targeted Treatment in Alopecia Areata - New Possibilities?

1 citations , May 2023 in “Prospects in Pharmaceutical Sciences”

New cytokine-targeted therapies show promise for treating alopecia areata.

research Learning From Success and Failure: Biologics for Non-Approved Skin Diseases

20 citations , August 2019 in “Frontiers in immunology”

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

research Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events

2 citations , April 2025 in “Biologics”

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

research Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature

February 2024 in “Curēus”

Secukinumab can cause hair loss, which may improve after stopping the medication.

View more "cosentyx" in research →

Community Join

0 / 0 results

— no results